Provided by Tiger Trade Technology Pte. Ltd.

Lucid Group Inc

3.38
-0.0517-1.51%
Volume:5.39M
Turnover:18.19M
Market Cap:1.33B
PE:-0.25
High:3.43
Open:3.40
Low:3.32
Close:3.44
52wk High:22.42
52wk Low:2.37
Shares:394.07M
Float Shares:157.00M
Volume Ratio:0.77
T/O Rate:3.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.6500
EPS(LYR):-11.8124
ROE:-125.99%
ROA:-30.70%
PB:-1.26
PE(LYR):-0.29

Loading ...

Lucid Group (LCID) Sets Up France Launch With More Than 16 Locations

Simply Wall St.
·
Yesterday

Lucid Group to Open First Three Retail & Service Locations in France in Q1 2027

Reuters
·
Yesterday

Lucid Group - Plans to Expand French Network to over 16 Locations by End of 2027

THOMSON REUTERS
·
Oct 12

Lucid Group - Orders for Lucid Vehicles in France Expected to Open in Q1 2027

THOMSON REUTERS
·
Oct 12

Lucid Group is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Oct 12

RBC Cuts Price Target on Lucid Group to $4 From $7, Keeps Sector Perform Rating

MT Newswires Live
·
Oct 12

Lucid Group’s EV Ambitions Face Mounting Market Doubts

TIPRANKS
·
Oct 10

Lucid Group Expands PIF-Backed Term Loan Financing

TIPRANKS
·
Oct 10

Lucid Group - Draws $400 Mln of Delayed Draw Term Loan on Oct 6, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 10

Lucid Group - Aggregate Principal Outstanding Under Ddtl is $2.10 Bln with $400 Mln Capacity Remaining - SEC Filing

THOMSON REUTERS
·
Oct 10

Lucid Draws $400 Million from Delayed-Draw Term Loan with PIF Affiliate Ayar Third Investment Company

Reuters
·
Oct 10

2 Negatives Don't Make a Positive When it Comes to Rivian and Volkswagen

Dow Jones
·
Oct 08

Saratoga Investment price target lowered to $19 from $20 at Lucid Capital

TIPRANKS
·
Oct 08

Quantum BioPharma (NASDAQ: QNTM) Enlists Thermo Fisher’s Clinical Research Business to Launch Phase 2 Lucid-MS Trial

TIPRANKS
·
Oct 08

Innventure Launches ATM Offering to Fund Accelsius Focus

TIPRANKS
·
Oct 07

Lucid reaffirming 2026 cash flow improvement view is ‘encouraging,’ says Cantor

TIPRANKS
·
Oct 07

BNP sees ‘difficult journey’ for Lucid after ‘lackluster’ Q3 deliveries

TIPRANKS
·
Oct 07

Lucid Group Q3 deliveries miss expectations, says StoneX

TIPRANKS
·
Oct 07

Quantum BioPharma (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial

TIPRANKS
·
Oct 07

Cantor Fitzgerald Sticks to Its Hold Rating for Lucid Group (LCID)

TIPRANKS
·
Oct 06